A Molecular Take on Malignant Rhabdoid Tumors
- PMID: 28741508
- DOI: 10.1016/j.trecan.2016.04.003
A Molecular Take on Malignant Rhabdoid Tumors
Abstract
The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular intertumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic, and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.
Keywords: malignant rhabdoid tumors; molecular analysis; pediatric cancer; sequencing.
Copyright © 2016 Elsevier Inc. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources